Orchestra BioMed Holdings, Inc. Debt Securities, Available-for-sale, Realized Gain
Orchestra BioMed Holdings, Inc. (OBIO) reported Debt Securities, Available-for-sale, Realized Gain of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGain · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2026-06-30 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2026-03-31 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2025-09-30 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain for the quarter ending 2025-06-30 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain for fiscal 2024 was $11.00K.
| Period end | Debt Securities, Available-for-sale, Realized Gain 3 month | Debt Securities, Available-for-sale, Realized Gain 3 month as first filed | Debt Securities, Available-for-sale, Realized Gain 6 month | Debt Securities, Available-for-sale, Realized Gain 9 month | Debt Securities, Available-for-sale, Realized Gain 9 month as first filed | Debt Securities, Available-for-sale, Realized Gain 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | |||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2025-11-10 | $11.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $11.00K derived: sum of 3 quarters · filed 2026-08-10 | $11.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | $11.00K derived: sum of 2 quarters · filed 2026-05-12 | $11.00K derived: sum of 3 quarters · filed 2026-05-12 | $11.00K derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $11.00K derived: sum of 2 quarters · filed 2025-11-10 | $11.00K derived: sum of 3 quarters · filed 2025-11-10 | $11.00K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | $10.00K 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $11.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |